AIM
SRNE

Assured Investment Management’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

Assured Investment Management’s Portfolio SRNE Stock Details SRNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-18,332
Closed -$132K – 1338
2018
Q2 		$132K Buy
+18,332
New +$125K ﹤0.01% 1054

Other funds holding SRNE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
IP
Intellectus Partners San Francisco, California $490M AUM 35.11% 1-Year Est. Return
WCM
Wildcat Capital Management New York $229M AUM 132.65% 1-Year Est. Return

Assured Investment Management's SRNE Position: Q3 2018 in Review

Assured Investment Management sold out of Sorrento Therapeutics, Inc. (SRNE) in Q3 2018, closing a stake of 18,332 shares — an estimated $132K sold.

Assured Investment Management first reported a position in SRNE in Q2 2018 and held it in 1 quarter. The position peaked at $132K in Q2 2018. 97 funds tracked by Wall St. Rank hold SRNE as of Q3 2018.

  • Assured Investment Management reported no remaining Sorrento Therapeutics, Inc. position as of Q3 2018 after selling out during the quarter.
  • Assured Investment Management sold 18,332 Sorrento Therapeutics, Inc. shares in Q3 2018, an estimated $132K.
  • Assured Investment Management first reported a position in Sorrento Therapeutics, Inc. in Q2 2018 and held it in 1 quarter.
  • Assured Investment Management's Sorrento Therapeutics, Inc. position peaked at $132K in Q2 2018.
  • 97 funds tracked by Wall St. Rank held Sorrento Therapeutics, Inc. as of Q3 2018.

Based on Assured Investment Management's 13F filing for Q3 2018, filed 14 Nov 2018.